These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 22883544)

  • 1. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate.
    Corazza O; Demetrovics Z; van den Brink W; Schifano F
    Int J Drug Policy; 2013 Jan; 24(1):82-3. PubMed ID: 22883544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Legal and illegal drugs--status, selected problems, trends].
    Katzung W
    Z Arztl Fortbild (Jena); 1992 Jul; 86(14):689-99. PubMed ID: 1529620
    [No Abstract]   [Full Text] [Related]  

  • 3. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
    Rychert M; Wilkins C
    Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling new drugs under marketing regulations.
    Hughes B; Winstock AR
    Addiction; 2012 Nov; 107(11):1894-9. PubMed ID: 22288473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No quick fix for legal highs.
    Parsons J
    Addiction; 2012 Nov; 107(11):2053-4; author reply 2054-5. PubMed ID: 23039756
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited use of novel psychoactive substances in South London nightclubs.
    Wood DM; Hunter L; Measham F; Dargan PI
    QJM; 2012 Oct; 105(10):959-64. PubMed ID: 22718853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
    Rychert M; Wilkins C
    Int J Drug Policy; 2016 Nov; 37():90-97. PubMed ID: 27639994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should "legal highs" be regulated as medicinal products?
    Evans-Brown M; Bellis MA; McVeigh J
    BMJ; 2011 Feb; 342():d1101. PubMed ID: 21345907
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to commentaries.
    Wilkins C
    Addiction; 2014 Oct; 109(10):1593-4. PubMed ID: 25163708
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of legal bans on poison control center contacts regarding 'legal highs'.
    Loeffler G; Craig C
    Addiction; 2013 Jul; 108(7):1348-9. PubMed ID: 23617711
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of the prohibition of benzylpiperazine (BZP) 'legal highs' on the prevalence of BZP, new legal highs and other drug use in New Zealand.
    Wilkins C; Sweetsur P
    Drug Alcohol Depend; 2013 Jan; 127(1-3):72-80. PubMed ID: 22819869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The World Health Organization's Expert Committee on drug dependence: comments on the 28th report (1994).
    Negrete JC
    Addiction; 1995 Nov; 90(11):1437-9. PubMed ID: 8528021
    [No Abstract]   [Full Text] [Related]  

  • 13. [From an illegal drug (so-called non-medically used psychoactive drug) to the designated substance (Shitei-yakubutsu) controlled by the Pharmaceutical Affairs Law in Japan--approach from the laboratory examination to the regulation].
    Satoh K; Kojima T
    Yakugaku Zasshi; 2013; 133(1):1-2. PubMed ID: 23292011
    [No Abstract]   [Full Text] [Related]  

  • 14. Appraisal of the narcotic drugs and psychotropic substances (amendment) act, 2014.
    Mohapatra S; Rath N
    Asian J Psychiatr; 2015 Apr; 14():80-1. PubMed ID: 25838083
    [No Abstract]   [Full Text] [Related]  

  • 15. 'Heads held high': an exploratory study of legal highs in pre-legislation Ireland.
    Van Hout MC; Brennan R
    J Ethn Subst Abuse; 2011; 10(3):256-72. PubMed ID: 21888502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Zealand to establish fit for purpose regulation for new psychoactive substances.
    Sheridan J; Atmore B; Russell B
    Addiction; 2012 Nov; 107(11):1901-2. PubMed ID: 23039748
    [No Abstract]   [Full Text] [Related]  

  • 17. "Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.
    Corazza O; Valeriani G; Bersani FS; Corkery J; Martinotti G; Bersani G; Schifano F
    J Psychoactive Drugs; 2014; 46(4):287-94. PubMed ID: 25188698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is drug prohibition an effective tool? An analysis from the forensic viewpoint].
    Stratenwerth G
    Psychiatr Prax; 1994 Jan; 21(1):3-6. PubMed ID: 8146243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.
    Gibbons S
    Clin Toxicol (Phila); 2012 Jan; 50(1):15-24. PubMed ID: 22248120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [All drugs banned soon allowed? (1)].
    Nau JY
    Rev Med Suisse; 2010 Sep; 6(262):1738-9. PubMed ID: 21298815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.